PREFER - Why, when and how to assess and use patient preferences in medical product decision-making

Part of EU Open Research Repository
Published December 7, 2021 | Version v1
Other Open

Identification of candidate methodologies and criteria to assess empirical case and simulation studies

Creators

  • 1. University of Rotterdam
  • 2. Sanofi
  • 3. Johnson & Johnson

Description

This task identified 13 elicitation and exploration methods likely to meet most decision-makers’ needs throughout the MPLC. The selection of an elicitation or exploration method ultimately depends on the research question, objectives, and feasibility of the patient preference study. The weighted approach described in this report provides valuable support as decision-makers choose which preference method to use in a given situation.

Files

115966_PREFER_Deliverable_2.7_final_updated.pdf

Files (2.7 MB)

Additional details

Funding

European Commission
PREFER – Patient Preferences in benefit risk assessments during the drug life cycle - Sofia ref.: 115966 115966